RAMOSETRON HYDROCHLORIDE MARKET ANALYSIS
Based on region, the global ramosetron hydrochloride market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America region is anticipated to dominant in the growth of global ramosetron hydrochloride market attributed to prevalence of irritable bowel syndrome in U.S. For instance, Centers for Disease Control and Prevention 2015 statistics estimated 1.3% of U.S. adults (3 million) being diagnosed with irritable bowel syndrome.
Asia Pacific region is estimated to perceive noteworthy growth in the global Ramosetron Hydrochloride market owing to rising approvals for licensing of drug by regulatory bodies. For instance, in April 2015, Ministry of Health, Labour and Welfare, Japan, and Pharmaceuticals and Medical Devices Agency (PMDA) concluded that ramosetron hydrochloride, manufactured by Astellas Pharma Inc. is effective in patients with diarrhea-predominant irritable bowel syndrome and the drug was approved for marketing.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
